Effect of chronic calcium antagonist treatment on dopamine recognition sites in rat striatum

This publication has 13 references indexed in Scilit:

• The Ca++-antagonist nimodipine decreases and the Ca++-agonist Bay K 8644 increases catecholamine synthesis in mouse brain
  Neuropharmacology, 1987
• In vivo effects of the Ca2+-antagonist nimodipine on dopamine metabolism in mouse brain
  Journal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1986
• Effect of lead exposure on dopaminergic receptors in rat striatum and nucleus accumbens
  Brain Research, 1986
• PARKINSONISM, TARDIVE DYSKINESIA, AKATHISIA, AND DEPRESSION INDUCED BY FLUNARIZINE
  The Lancet, 1986
• Bay K 8644 stimulation of calcium entry and endogenous dopamine release in rat striatal synaptosomes antagonized by nimodipine
  Brain Research, 1986
• Dopamine release is enhanced while acetylcholine release is inhibited by nimodipine (Bay e 9736)
  Acta Physiologica Scandinavica, 1986
• Dopamine inhibition of neurotensin-induced increase in Ca2+ influx into rat pituitary cells
  Brain Research, 1985
• Competitive inhibition of [3H]spiperone binding to D-2 dopamine receptors in striatal homogenates by organic calcium channel antagonists and polyvalent cations
  European Journal of Pharmacology, 1984
• Some calcium and lysosome antagonists inhibit 3H-spirerone binding to the porcine anterior pituitary
  Life Sciences, 1982
• Dopamine inhibition of action potentials in a prolactin secreting cell line is modulated by oestrogen
  Nature, 1979